Tredje AP fonden lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 50.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,178 shares of the company’s stock after selling 10,178 shares during the quarter. Tredje AP fonden’s holdings in Henry Schein were worth $704,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently bought and sold shares of the company. Principal Financial Group Inc. lifted its stake in shares of Henry Schein by 2.1% in the third quarter. Principal Financial Group Inc. now owns 145,835 shares of the company’s stock worth $10,631,000 after acquiring an additional 3,037 shares in the last quarter. Huntington National Bank increased its holdings in shares of Henry Schein by 16.8% in the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company’s stock worth $110,000 after acquiring an additional 218 shares during the period. Tokio Marine Asset Management Co. Ltd. bought a new stake in shares of Henry Schein during the third quarter valued at approximately $301,000. CIBC Asset Management Inc raised its stake in Henry Schein by 7.0% during the 3rd quarter. CIBC Asset Management Inc now owns 17,680 shares of the company’s stock valued at $1,289,000 after acquiring an additional 1,162 shares in the last quarter. Finally, Natixis Advisors LLC lifted its holdings in Henry Schein by 18.8% in the third quarter. Natixis Advisors LLC now owns 81,877 shares of the company’s stock worth $5,969,000 after purchasing an additional 12,930 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on HSIC. Barrington Research restated an “outperform” rating and set a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Wells Fargo & Company started coverage on shares of Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target on the stock. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.
Henry Schein Stock Up 1.1 %
Henry Schein stock opened at $70.58 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company’s 50-day moving average is $74.84 and its 200-day moving average is $72.60. The firm has a market capitalization of $8.76 billion, a PE ratio of 29.05, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.49.
Henry Schein (NASDAQ:HSIC – Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.66 earnings per share. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- The Most Important Warren Buffett Stock for Investors: His Own
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to Calculate Options Profits
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.